Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 419-560-6 | CAS number: 4369-14-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 14th November 1994 - 7th December 1994
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- The study was conducted according to an older (1981) version of OECD Test Guideline 474, with only a single dose used at the initial sampling time and only 1000 peripheral erythrocytes scored for micronuclei.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 995
- Report date:
- 1995
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- 1981
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- mammalian bone marrow chromosome aberration test
Test material
- Reference substance name:
- -
- EC Number:
- 419-560-6
- EC Name:
- -
- Cas Number:
- 4369-14-6
- Molecular formula:
- C9H18O5Si
- IUPAC Name:
- 3-(trimethoxysilyl)propyl prop-2-enoate
- Test material form:
- liquid
1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Ltd., Manston, Kent
- Age at study initiation: 5-8 weeks old
- Weight at study initiation: males 22-29 g (males, females 20-24 g
- Assigned to test groups randomly: Yes
- Fasting period before study: Not specified
- Housing: In groups of 5 per sex
- Diet (e.g. ad libitum): Rat and Mouse Expanded diet No. 1, ad libitum
- Water (e.g. ad libitum): Mains drinking water, ad libitum
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-22
- Humidity (%): 51-53
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- intraperitoneal
- Vehicle:
- - Vehicle(s)/solvent(s) used: Arachis oil
- Justification for choice of solvent/vehicle: Not specified
- Concentration of test material in vehicle: 100 mg/mL
- Dose volume: 10 mL/kg
- Lot/batch no. (if required): 010699
- Purity: Not specified - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test material was freshly prepared as required as a suspension at the appropriate concentration in arachis oil. - Duration of treatment / exposure:
- Single intraperitoneal dose
- Frequency of treatment:
- Single exposure
- Post exposure period:
- 24, 48 or 72 hours
Doses / concentrations
- Dose / conc.:
- 1 000 mg/kg bw (total dose)
- No. of animals per sex per dose:
- 5M, 5F
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide Monohydrate
- Justification for choice of positive control(s): The substance is known to produce micronuclei under the conditions of the test.
- Route of administration: Oral dose
- Doses / concentrations: Dose 50 mg/kg bw; concentration 5 mg/mL; dose volume 10 mL/kg
Examinations
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
Based on the findings of a dose range-finding study. The dose tested in the micronucleus test was the maximum tolerated dose.
TREATMENT AND SAMPLING TIMES:
Three groups of 5 male and 5 female mice where each animals was dosed via the intraperitoneal route with the test material at 1000 mg/kg bw. One group of mice was killed at 24 hours following the treatment, the second group was killed at 48 hours and the third at 72 hours post-treatment.
DETAILS OF SLIDE PREPARATION:
Immediately following sacrifice (at 24, 48 and 72 hours), one femur was dissected from each animal, aspirated with foetal calf serum and bone marrow smears prepared following centrifugation and re-suspension. The smears were air-dried, fixed in absolute methanol and stained in May-Grunwald/Giemsa.
METHOD OF ANALYSIS:
Stained bone marrow smears were coded and examined blind using light microscopy at x1000 magnification. The incidence of micronucleated cells per 1000 PCEs (blue stained immature cells) per animal was scored. In addition, the NCEs (pink stained mature cells) associated with 1000 polychromatic erythrocytes were counted; these cells are also scored for incidence of micronuclei. The ratio of NCEs to PCEs was calculated together with appropriate group mean values for males and females separately and combined. - Evaluation criteria:
- A positive mutagenic response is demonstrated when a statistically significant increase in the number of micronucleated polychromatic erythrocytes is observed for either the 24, 48 or 72-hour kill times. If these criteria are not demonstrated, then the test material is considered to be non-genotoxic under the conditions of the test. A positive response for bone marrow toxicity is demonstrated when the dose group mean normochromatic to poluchromatic ratio is shown to be statistically significant from the concurrent vehicle control group.
- Statistics:
- All data were statistically analysed, withg group means, standard deviation, and NCE: PCE ratios calculated and statistical significance determined,
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY:
- Dose range: 400, 800, 1250, 2500 mg/kg bw
- Solubility: Not assessed
- Clinical signs of toxicity in test animals: Clinical signs were observed in animals dosed at and above 1250 mg/kg bw and included lethargy, decreased respiratory rate, laboured respiration, ataxia, pallor of the extremities, ptosis and hunched posture. Premature deaths were seen in one animal dosed at 1250 mg/kg bw and in two animals at 2500 mg/kg bw. Since no clinical signs were seen at 800 mg/kg bw and one premature death seen at 1250 mg/kg bw, the dose level selected as the maximum tolerated dose was 1000 mg/kg bw.
- Evidence of cytotoxicity in tissue analyzed: Not specified
- Rationale for exposure: To determine the suitable dose level for the micronucleus study. The dose level selected should be the maximum tolerated dose level or that which produces some evidence of cytotoxicity up to a maximum dose of 5000 mg/kg bw.
- Harvest times: No tissue harvest performed
- High dose with and without activation: The high dose was 2500 mg/kg bw and metabolic activation was not used in the study.
RESULTS OF DEFINITIVE STUDY:
- Types of structural aberrations for significant dose levels (for Cytogenetic or SCE assay): Not specified
- Induction of micronuclei (for micronucleus assay): There was no statistically significant increase in the frequency of micronucleated PCEs in any of the test material dose groups when compared to the control group.
- Ratio of NCE/PCE (for micronucleus assay): There was no statistically significant change in the NCE/PCE ratio in any of the test material dose groups when compared to their concurrent controls, although the presence of clinical signs indicated that systemic absorption had occurred.
- Appropriateness of dose levels and route: Premature deaths were seen for one animal at 48 hours and two at 72 hours. Clinical signs were seen in the dosed animals and included lethargy, decreased respiratory rate, laboured respiration, ataxia and tiptoe gait.
- Statistical evaluation: No statistically significant changes were seen in the dosed groups.
Applicant's summary and conclusion
- Conclusions:
- 3-(Trimethoxysilyl)propyl acrylate has been tested for its ability to induce micronuclei in vivo in male and female CD-1 mice in a study conducted according to OECD Test Guideline 474 and in compliance with GLP (reliability score 2). There was no statistically significant increase in the frequency of micronucleated PCEs in any of the test material dose groups when compared to the control group. There was no statistically significant change in the NCE/PCE ratio in any of the test material dose groups when compared to their concurrent controls, although the presence of clinical signs indicated that systemic absorption had occurred. Appropriate negative (treatment medium) and positive controls were included and gave expected results. It is concluded that the test substance is negative for the induction of micronuclei under the conditions of this in vivo study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.